+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Dental Bone Graft Substitutes Market Analysis - COVID19 - 2021-2027 - MedSuite - Includes: Dental Bone Graft Substitutes, Dental Growth Factor & Dental Barrier Membrane Devices

  • PDF Icon

    Report

  • December 2020
  • Region: United States
  • iData Research
  • ID: 5314402
Throughout this medical market research, the publisher analyzed 41 dental bone graft substitutes device companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of US Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.

Markets Covered
  • Dental Bone Graft Substitute Market - MedCore
  • Dental Growth Factor Market - MedCore
  • Dental Barrier Membrane Market - MedCore

US Dental Bone Graft Substitutes Market Insights

In 2020, the US dental bone graft substitutes market size was valued at over $316 million, which declined at -21% when compared to 2019. In spite of COVID19, the US market size is expected to increase over the forecast period to exceed $540 million in 2027.

One trend within the dental bone graft substitute and other biomaterials markets is the bundling of DBGS materials with large-volume implant purchases, rendering the products extremely discounted or even complimentary. Because periodontists and oral surgeons outnumber general practitioners in terms of the number of dentists placing implants in the United States, and because these specialists tend to buy in bulk, this trend is expected to persist in the future. Free DBGS products limit the market by dragging down the overall market value.

Geistlich was the leader of the dental biomaterials market in the U.S. in 2020. Its prominence in the overall market is fueled primarily by the company’s continued leadership in the xenograft DBGS segment. Geistlich’s Bio-Oss® bovine xenograft product line is recognized as the gold standard for xenograft products and correspondingly represented about two-thirds of the xenograft segment.

Table of Contents

Table of ContentsList of FiguresList of ChartsExecutive SummaryU.S. Dental Bone Graft Substitute and Other Biomaterials Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsMarkets IncludedKey Report UpdatesVersion History
Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
Impact of COVID-19 on the U.S. Dental Bone Graft Substitute and Other Biomaterials Market
2.1 Introduction
2.2 Multi-Scenario Analysis
2.2.1.1 Best Case Scenario
2.2.1.2 Base Case Scenario
2.2.1.3 Worst Case Scenario
Disease Overview
3.1 Basic Anatomy
3.1.1 Dental Anatomy: Oral Cavity and Intraoral Landmarks
3.2 Disease Pathology and Disorders
3.2.1 General Diagnostics
3.2.2 Indication for Dental Implant
3.2.3 Periodontal Disease
3.2.4 Dental Implant Procedures
3.2.5 Guided Bone Regeneration
3.3 Patient Demographics
3.3.1 General Dental Statistics
3.3.2 Tooth Loss Statistics
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Dental Bone Graft Substitutes
4.2.1.1 Allografts
4.2.1.1.1 Mineralized Allografts
4.2.1.1.2 Demineralized Bone Matrix
4.2.1.2 Autografts
4.2.1.3 Synthetics
4.2.1.4 Xenografts
4.2.2 Dental Growth Factors
4.2.3 Dental Barrier Membrane
4.3 Regulatory Issues and Recalls
4.3.1 Geistlich
4.4 Clinical Trials
4.4.1 Dental Grafts
U.S. Dental Bone Graft Substitute and Other Biomaterials Market Overview
5.1 Introduction
5.1.1 Applications of Dental Bone Graft Substitutes
5.1.1.1 Dental Implant Procedures
5.1.1.2 Periodontal Procedures
5.1.2 Types of Dental Bone Graft Substitutes
5.1.2.1 Autografts
5.1.2.2 Allografts
5.1.2.3 Demineralized Bone Matrix Allografts
5.1.2.4 Xenografts
5.1.2.5 Synthetics
5.1.3 Dental Growth Factor Products
5.1.4 Dental Membranes
5.1.5 Market Penetration and End-users
5.2 Market Overview
5.3 Trend Analysis by Segment
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
5.6 Mergers and Acquisitions
5.7 Company Profiles
5.7.1 Ace Surgical
5.7.2 Biohorizons
5.7.3 Dentsply Sirona
5.7.4 Geistlich
5.7.5 Lifenet Health
5.7.6 Medtronic
5.7.7 Osteogenics Biomedical
5.7.8 Zimmer Biomet
5.8 SWOT Analysis
5.8.1 Ace Surgical
5.8.2 Biohorizons
5.8.4 Dentsply Sirona
5.8.5 Geistlich
5.8.6 Lifenet Health
5.8.7 Medtronic
5.8.8 Osteogenics Biomedical
5.8.9 Zimmer Biomet
Procedure Numbers
6.1 Introduction
6.2 Dental Bone Grafting Procedures
Dental Bone Graft Substitute Market
7.1 Introduction
7.1.1 Autografts
7.1.2 Allografts
7.1.2.1 Mineralized Allografts
7.1.2.2 Demineralized Bone Matrix
7.1.3 Xenografts
7.1.4 Synthetics
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Dental Bone Graft Substitute Market
7.3.2 Total Allograft Market
7.3.2.1 Mineralized Allograft Market
7.3.2.2 Demineralized Bone Matrix Allograft Market
7.3.3 Xenograft Market
7.3.4 Synthetic Bone Graft Market
7.4 Unit Analysis
7.4.1 Bone Graft Substitute Unit Sales by Type
7.5 Drivers and Limiters
7.5.1 Market Drivers
7.5.2 Market Limiters
7.6 Competitive Market Share Analysis
Dental Growth Factor Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Emdogain® Market
8.3.2 Gem 21S® Market
8.3.3 Infuse® Market
8.3.4 Osteocel® Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
Dental Barrier Membrane Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Total Dental Barrier Membrane Market
9.3.2 Resorbable Dental Barrier Membrane Market
9.3.3 Non-Resorbable Dental Barrier Membrane Market
9.3.3.1 Non-Reinforced Non-Resorbable Dental Barrier Membrane Market
9.3.3.2 Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market
9.4 Unit Analysis
9.4.1 Dental Barrier Membrane Unit Sales by Size
9.4.1.1 Resorbable Dental Barrier Membranes by Size
9.4.1.2 Non-Resorbable Dental Barrier Membranes by Size
9.4.2 Dental Barrier Membrane Unit Sales by Material
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AB Dental
  • ACE Surgical
  • Benco
  • Bicon
  • BioHorizons
  • BioMimetic
  • Botiss Biomaterials
  • BTI
  • Collagen Matrix
  • Cortex Dental
  • Curasan
  • Datum Dental
  • Dentium USA
  • Dentsply Sirona
  • Dyna Dental
  • Envista
  • Exactech
  • Geistlich
  • Halma
  • Henry Schein
  • Impladent LTD
  • Implant Direct
  • Inion
  • KaVo Kerr
  • Keystone Dental
  • LifeNet Health
  • Lutipold Pharmaceuticals
  • Lynch Biologics
  • Medtronic
  • MegaGen
  • Nobel Biocare
  • Osteogenics Biomedical
  • Osteohealth
  • Patterson
  • Regentix
  • Salvin
  • Snoasis Medical
  • Straumann Group
  • Tissue Banks
  • Unicare Biomedical
  • Zimmer Biomet